Article

Improved prostate cancer prediction by combining Prostate-Specific Antigen (PSA) test results with Genetic Risk Scores (GRS/PRS)

2026-05-18

Abstract excerpt

<h4>Background: </h4> Prostate cancer is the second most common cancer in men worldwide. The Prostate Specific Antigen (PSA) blood test is widely used for prostate cancer detection but suffers from high false-positive rates (up to 80%). Genetic risk scores (GRS/PRS) have a similar performance to PSA testing in predicting prostate cancer risk. <h4>Method:</h4> GRS269 for prostate cancer was derived using 269 known...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 33b04394-3cba-5e22-91c1-4430d892aec9
DOI: 10.64898/2026.05.14.26353195

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Improved prostate cancer prediction by combining Prostate-Specific Antigen (PSA) test results with Genetic Risk Scores (GRS/PRS)DOI 10.64898/2026.05.14.26353195Read

Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.Semantic proximity Read

Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK BiobankSemantic proximity Read

Precision Prostate Cancer Screening with a Polygenic Risk ScoreSemantic proximity Read

Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.Semantic proximity Read

Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.Semantic proximity Read

A comparison of genetic risk score with family history for estimating prostate cancer risk.Semantic proximity Read

Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study.Semantic proximity Read

A genetic risk score to guide age-specific, personalized prostate cancer screeningSemantic proximity Read

A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation.Semantic proximity Read

Validation of a prostate cancer polygenic risk score.Semantic proximity Read

Clinical validity and utility of genetic risk scores in prostate cancer.Semantic proximity Read

Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening.Semantic proximity Read